Collection of Blood Samples From HIV Infected People

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00096772
First received: November 15, 2004
Last updated: April 15, 2014
Last verified: April 2014

November 15, 2004
April 15, 2014
January 2005
September 2007   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00096772 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Collection of Blood Samples From HIV Infected People
Collection and Use of Blood For Genetic and Other Related Analyses (The GENOMICS Protocol)

The purpose of this study is to collect blood samples from HIV infected individuals for use in future genetic studies.

Genetic differences among people with HIV may account for differences in disease progression and response to antiretroviral therapy. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) was created to conduct studies in HIV infected communities and particularly in people of color, women, and injection drug users. This study will collect whole blood samples from HIV infected individuals. The samples will be used in future CPCRA studies comparing human genetic factors with clinical data from other CPCRA studies.

Observational
Not Provided
Not Provided
Retention:   Samples With DNA
Description:

Whole blood

Non-Probability Sample

Study participants will be selected from those who have given informed consent for participation in a qualifying CPCRA clinical trial.

HIV Infections
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
2502
Not Provided
September 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Presently participating, previously participated in, or has given informed consent for participation in a qualifying CPCRA clinical trial
  • Signed informed consent
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00096772
CPCRA 066, 10052
Not Provided
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
Not Provided
Study Chair: Jonathan Uy, MD AIDS Research Alliance Chicago (ARAC), University of Illinois at Chicago
National Institute of Allergy and Infectious Diseases (NIAID)
April 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP